Prosight Management, LP Mirum Pharmaceuticals, Inc. Transaction History

Prosight Management, LP

$369 Million
Q2 2025

A detailed history of Prosight Management, LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 200,000 shares of MIRM stock, worth $14.4 Million. This represents 2.76% of its overall portfolio holdings.

Number of Shares

200,000

Previous 343,326 41.75%

Holding current value

$14.4 Million

Previous $15.5 Million 34.19%

% of portfolio

2.76%

Previous 5.51%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$38.39 - $51.11 $5.5 Million - $7.33 Million	-143,326 Reduced 41.75%	200,000 $10.2 Million
Q1 2025 May 15, 2025	SELL	$41.32 - $53.16 $4.45 Million - $5.73 Million	-107,801 Reduced 23.9%	343,326 $15.5 Million
Q4 2024 Feb 14, 2025	SELL	$37.85 - $46.65 $556,319 - $685,661	-14,698 Reduced 3.16%	451,127 $18.7 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $5.09 Million - $6.76 Million	151,025 Added 47.97%	465,825 $18.2 Million
Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $3.54 Million - $5.23 Million	-150,200 Reduced 32.3%	314,800 $10.8 Million
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $4.28 Million - $5.15 Million	171,699 Added 58.54%	465,000 $11.7 Million
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $1.63 Million - $2.1 Million	-60,207 Reduced 17.03%	293,301 $8.66 Million
Q3 2023 Nov 14, 2023	SELL	$24.63 - $32.85 $7.92 Million - $10.6 Million	-321,492 Reduced 47.63%	353,508 $11.2 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $2.52 Million - $3.22 Million	107,174 Added 18.87%	675,000 $17.5 Million
Q1 2023 May 12, 2023	BUY	$19.19 - $24.1 $4.97 Million - $6.24 Million	259,050 Added 83.9%	567,826 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $418,219 - $566,582	23,776 Added 8.34%	308,776 $6.02 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $2.47 Million - $3.64 Million	123,473 Added 76.44%	285,000 $5.99 Million
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $1.61 Million - $2.41 Million	87,597 Added 118.49%	161,527 $3.14 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $1.15 Million - $1.77 Million	73,930 New	73,930 $1.63 Million
Q1 2021 May 14, 2021	SELL	$16.29 - $21.92 $981,472 - $1.32 Million	-60,250 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.75 - $25.45 $948,937 - $1.53 Million	60,250 New	60,250 $1.05 Million

Others Institutions Holding MIRM

# of Institutions

230

Shares Held

56.1M

Call Options Held

25.3K

Put Options Held

98.9K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Account

Prosight Management, LP Mirum Pharmaceuticals, Inc. Transaction History